Jack A. Khattar

President, CEO, Director, Supernus Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.8M

Companies

Latest trade

Mar 13, 2026

Companies

Supernus Pharmaceuticals, Inc.President, CEO, Director −$7.2M

Trades

SUPN Sold 35,000 shares at $50.38 · planned $1.8M Mar 13

SUPN Sold 59,900 shares at $50.57 · planned $3.0M Oct 9

SUPN Sold 1,904 shares at $48.06 · planned $0.1M Oct 2

SUPN Sold 40,173 shares at $48.07 · planned $1.9M Oct 1

SUPN Sold 8,588 shares at $48.25 · planned $0.4M Sep 30

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.